| Literature DB >> 29214549 |
Manuela Crisan1, Liliana Halip1, Paulina Bourosh2, Sergiu Adrian Chicu3, Yurii Chumakov4.
Abstract
BACKGROUND: Nitroaromatic and chloronitroaromatic compounds have been a subject of great interest in industry and recently in medical-pharmaceutic field. 2-Chloro-4-nitro/2-chloro-5-nitrobenzoic acids and 4-nitrobenzoic acid are promising new agents for the treatment of main infectious killing diseases in the world: immunodeficiency diseases and tuberculosis.Entities:
Keywords: Chemical reactivity; Nitrobenzoic and chloronitrobenzoic acids and derivatives; Single crystal X-ray diffraction; Toxicity
Year: 2017 PMID: 29214549 PMCID: PMC5718998 DOI: 10.1186/s13065-017-0346-5
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Fig. 1An ORTEP view of the compounds 1–3 showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level and the charge-assisted hydrogen bonds are represented by dashed lines
Crystal data and structure refinement parameters for compounds 1–3
| Compound | 1 | 2 | 3a |
|---|---|---|---|
| Empirical formula | C9H11ClN2O5 | C9H13ClN2O6 | C9H12N2O5 |
| Formula weight | 262.65 | 280.66 | 228.21 |
| Temperature (K) | 293 (2) | 293 (2) | 293 (2) |
| Wavelength (Å) | 1.54184 | 1.54184 | 0.71073 |
| Crystal system | monoclinic | triclinic | monoclinic |
| Space group |
|
|
|
| Z | 4 | 2 | 4 |
| Unit cell dimensions | |||
| | 8.402 (2) | 7.019 (1) | 6.211 (2) |
| | 6.334 (1) | 9.512 (2) | 8.651 (3) |
| | 22.023 (4) | 9.740 (2) | 19.594 (5) |
| α (°) | 90 | 79.19 (3) | 90 |
| β (°) | 100.72 (3) | 88.58 (3) | 91.27 (2) |
| γ (°) | 90 | 78.42 (3) | 90 |
| | 1151.6 (4) | 625.7 (2) | 1052.6 (5) |
| | 1.515 | 1.490 | 1.440 |
| μ (mm−1) | 3.099 | 2.950 | 0.119 |
| | 544 | 292 | 480 |
| Crystal size (mm) | 0.22 × 0.14 × 0.07 | 0.15 × 0.12 × 0.08 | 0.35 × 0.4 × 0.6 |
| θ range for data collection (°) | 4.09–70.07 | 4.62–70.01 | 2.08–27.06 |
| Limiting indices | − 10 ≤ | − 8 ≤ | 0 ≤ |
| − 7 ≤ | − 4 ≤ | 0 ≤ | |
| − 26 ≤ | − 11 ≤ | − 25 ≤ | |
| Reflections collected/unique | 2336/2192 | 2370/2370 | 2501/2294 |
| Reflections with [ | 2010 | 2282 | 1761 |
| Parameters | 156 | 165 | 193 |
| Goodness-of-fit on F2 | 1.007 | 1.003 | 1.001 |
|
| 0.0384, 0.1128 | 0.0415, 0.1175 | 0.0371, 0.1023 |
|
| 0.0414, 0.1163 | 0.0424, 0.1187 | 0.0540, 0.11068 |
| Largest difference in peak and hole (e Å−3) | 0.330/− 0.311 | 0.385/− 0.315 | 0.265/− 0.212 |
aCrystallographic data of compound 3 [21] is presented here for comparison with compounds 1 and 2
Tabulated ΔpKa and hydrogen-bonding geometry (Å, °) for compounds 1–3
| ΔpKa | D–H…A | d(D–H) | d(H…A) | d(D…A) | (DHA) | Symmetry transformation for H-acceptor |
|---|---|---|---|---|---|---|
|
| ||||||
| 7.58 | N(1)–H(2)…O(2) | 0.89 | 1.86 | 2.747 (2) | 173 |
|
| N(1)–H(1)…O(2) | 0.89 | 2.12 | 2.815 (2) | 135 |
| |
| N(1)–H(3)…O(1) | 0.89 | 2.20 | 2.868 (2) | 131 | − | |
| O(1)–H(1)…O(3) | 0.82 | 1.87 | 2.681 (2) | 169 | − | |
|
| ||||||
| 7.33 | N(1)–H(1)…O(3) | 0.89 | 1.90 | 2.766 (2) | 164 |
|
| N(1)–H(2)…O(1) | 0.89 | 1.96 | 2.798 (2) | 156 | − | |
| N(1)–H(3)…O(1W) | 0.89 | 1.98 | 2.858 (2) | 171 | − | |
| O(1)–H(1)…O(3) | 0.82 | 1.90 | 2.716 (2) | 172 |
| |
| O(1W)–H(1)…O(2) | 0.97 | 1.99 | 2.857 (2) | 149 | − | |
| O(1W)–H(2)…O(2) | 1.05 | 1.71 | 2.754 (2) | 175 |
| |
|
| ||||||
| 6.07 | N(2)–H(2)…O(1) | 0.96 | 1.81 | 2.738 | 168 |
|
| O(5)–H(5)…O(2) | 0.87 | 1.81 | 2.683 | 177 |
| |
| N(2)–H(2)…O(5) | 0.94 | 1.88 | 2.788 | 162 | − | |
| N(2)–H(2)…O(2) | 0.94 | 1.81 | 2.757 | 170 |
| |
D and A are hydrogen bond donor and acceptor atoms. ΔpKa = pKa (base) − pKa (acid) were calculated using the pKa data from Ref. [38]. All pKa values have been determined in aqueous solutions
aData of compound 3 [21] are presented here for comparison with compounds 1 and 2
Fig. 2Intramolecular hydrogen bonds resulting in synthons, layer and crystal packing in compound 1. a The R4 4(18) synthon formed by hydrogen bonds in compound 1; b the chains formed by hydrogen bonds in 1; c the crystal packing of 1 showing the weak interactions between the chains via C–O hydrogen bonds
Fig. 3Intramolecular hydrogen bonds resulting in synthons, layer and crystal packing in compound 2. a The R3 3(11) synthons linked by synthon R4 2(8) formed by hydrogen bonds in compound 2; b the layer formed by hydrogen bonds in 2; c the crystal packing of 2 showing the arrangement of the layers in the crystal
Fig. 4HOMO and LUMO orbitals for compounds 1–3
Chemical reactivity descriptors
| Compound | Toxicity (logMRC50) | EHOMO (eV) | ELUMO (eV) | Egap (eV) | µ (eV) | χ (eV) | ω (eV) |
|---|---|---|---|---|---|---|---|
| 1 | 3.10 | − 8.77077 | 2.20467 | 10.975 | − 3.283 | 3.283 | 0.982 |
| 2 | 3.22 | − 9.08751 | 1.61091 | 10.698 | − 3.738 | 3.738 | 1.306 |
| 3 | 1.78 | − 6.71305 | − 4.72281 | 1.99 | − 5.718 | 5.718 | 16.43 |
Chemical stability descriptors
| Compound | Toxicity (logMRC50) | Heat of formation (kcal mol−1) | Dipole | Η (eV) |
|---|---|---|---|---|
| 1 | 3.10 | − 117.42 | 19.5258 | 5.488 |
| 2 | 3.22 | − 121.19 | 17.5964 | 5.349 |
| 3 | 1.78 | − 120.54 | 11.4651 | 0.995 |
Fig. 5Distribution of compounds 1–3 based on their chemical reactivity and stability
Ionization potentials and acidic constants for anions A1–A3
| Anion | Ionization potential (eV) | pKaa |
|---|---|---|
| A1 | 5.578062 | 1.92 |
| A2 | 5.337785 | 2.17 |
| A3 | 4.475456 | 3.43 |
apKa of correspondent carboxylic acid [38]